Zai Lab and argenx report Phase 3 trial win for myositis drug

August 17, 2026 6:00 AM

Zai Lab (NASDAQ: ZLAB; HKEX: 9688) and argenx (Euronext & NASDAQ: ARGX) announced positive topline results from the Phase 3 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found